221 related articles for article (PubMed ID: 10415940)
1. Moxonidine acting centrally inhibits airway reflex responses.
Haxhiu MA; Dreshaj IA; McFadden CB; Erokwu BO; Ernsberger P
Ann N Y Acad Sci; 1999 Jun; 881():372-82. PubMed ID: 10415940
[TBL] [Abstract][Full Text] [Related]
2. I1-imidazoline receptors and cholinergic outflow to the airways.
Haxhiu MA; Dreshaj IA; McFadden CB; Erokwu BO; Ernsberger P
J Auton Nerv Syst; 1998 Jul; 71(2-3):167-74. PubMed ID: 9760053
[TBL] [Abstract][Full Text] [Related]
3. Selective antihypertensive action of moxonidine is mediated mainly by I1-imidazoline receptors in the rostral ventrolateral medulla.
Haxhiu MA; Dreshaj I; Schäfer SG; Ernsberger P
J Cardiovasc Pharmacol; 1994; 24 Suppl 1():S1-8. PubMed ID: 7533221
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the receptor involved in the central hypotensive effect of rilmenidine and moxonidine.
Bock C; Niederhoffer N; Szabo B
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):262-71. PubMed ID: 10344524
[TBL] [Abstract][Full Text] [Related]
5. Role of I1 imidazoline receptors in the sympathoinhibition produced by intracisternally administered rilmenidine and moxonidine.
Szabo B; Urban R
Arzneimittelforschung; 1997 Sep; 47(9):1009-15. PubMed ID: 9342413
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of moxonidine, an I1-imidazoline receptor agonist.
Ziegler D; Haxhiu MA; Kaan EC; Papp JG; Ernsberger P
J Cardiovasc Pharmacol; 1996; 27 Suppl 3():S26-37. PubMed ID: 8872297
[TBL] [Abstract][Full Text] [Related]
7. alpha(2)-adrenergic receptors are not required for central anti-hypertensive action of moxonidine in mice.
Tolentino-Silva FP; Haxhiu MA; Waldbaum S; Dreshaj IA; Ernsberger P
Brain Res; 2000 Apr; 862(1-2):26-35. PubMed ID: 10799665
[TBL] [Abstract][Full Text] [Related]
8. Site-dependent inhibition of neuronal c-jun in the brainstem elicited by imidazoline I1 receptor activation: role in rilmenidine-evoked hypotension.
Wang X; Li G; Abdel-Rahman AA
Eur J Pharmacol; 2005 May; 514(2-3):191-9. PubMed ID: 15910806
[TBL] [Abstract][Full Text] [Related]
9. Role of imidazoline receptors in the cardiovascular actions of moxonidine, rilmenidine and clonidine in conscious rabbits.
Chan CK; Sannajust F; Head GA
J Pharmacol Exp Ther; 1996 Feb; 276(2):411-20. PubMed ID: 8632304
[TBL] [Abstract][Full Text] [Related]
10. Receptors involved in moxonidine-stimulated atrial natriuretic peptide release from isolated normotensive rat hearts.
Mukaddam-Daher S; Menaouar A; Gutkowska J
Eur J Pharmacol; 2006 Jul; 541(1-2):73-9. PubMed ID: 16774751
[TBL] [Abstract][Full Text] [Related]
11. Relative importance of central imidazoline receptors for the antihypertensive effects of moxonidine and rilmenidine.
Chan CK; Head GA
J Hypertens; 1996 Jul; 14(7):855-64. PubMed ID: 8818924
[TBL] [Abstract][Full Text] [Related]
12. The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease.
Ernsberger P; Friedman JE; Koletsky RJ
J Hypertens Suppl; 1997 Jan; 15(1):S9-23. PubMed ID: 9050981
[TBL] [Abstract][Full Text] [Related]
13. I1-imidazoline-receptor agonists in the treatment of hypertension: an appraisal of clinical experience.
Ollivier JP; Christen MO
J Cardiovasc Pharmacol; 1994; 24 Suppl 1():S39-48. PubMed ID: 7533226
[TBL] [Abstract][Full Text] [Related]
14. Moxonidine inhibits excitatory inputs to airway vagal preganglionic neurons via activation of both α
Zhou X; He D; Yan X; Chen X; Li R; Zhang G; Wang J
Brain Res; 2020 Apr; 1732():146695. PubMed ID: 32007398
[TBL] [Abstract][Full Text] [Related]
15. Why imidazoline receptor modulator in the treatment of hypertension?
Schäfer SG; Kaan EC; Christen MO; Löw-Kröger A; Mest HJ; Molderings GJ
Ann N Y Acad Sci; 1995 Jul; 763():659-72. PubMed ID: 7677385
[TBL] [Abstract][Full Text] [Related]
16. Role of I(1)-imidazoline receptors and alpha2-adrenoceptors in hemodynamic effects of moxonidine administration into the rostroventrolateral medulla.
Khokhlova ON; Murashev AN; Medvedev OS
Bull Exp Biol Med; 2001 Apr; 131(4):336-9. PubMed ID: 11550020
[TBL] [Abstract][Full Text] [Related]
17. Involvement of alpha 2-adrenoceptors in the cardiovascular effects of moxonidine.
Urban R; Szabo B; Starke K
Eur J Pharmacol; 1995 Aug; 282(1-3):19-28. PubMed ID: 7498275
[TBL] [Abstract][Full Text] [Related]
18. Augmentation of moxonidine-induced increase in ANP release by atrial hypertrophy.
Cao C; Kang CW; Kim SZ; Kim SH
Am J Physiol Heart Circ Physiol; 2004 Jul; 287(1):H150-6. PubMed ID: 14975931
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
Prichard BN; Owens CW; Graham BR
J Hum Hypertens; 1997 Aug; 11 Suppl 1():S29-45. PubMed ID: 9321737
[TBL] [Abstract][Full Text] [Related]
20. Presynaptic effects of moxonidine in isolated buffer perfused rat hearts: role of imidazoline-1 receptors and alpha2-adrenoceptors.
Schäfer U; Burgdorf C; Engelhardt A; Kurz T; Richardt G
J Pharmacol Exp Ther; 2002 Dec; 303(3):1163-70. PubMed ID: 12438540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]